We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Clinical Immunoanalyzers Market to Be Driven by High Incidence of Chronic and Infectious Diseases

By LabMedica International staff writers
Posted on 28 Dec 2021
Print article

The global clinical immunoanalyzers market has been witnessing high demand due to the high prevalence and incidence rates of chronic and infectious diseases, rapid growth in the elderly population, strong economic growth in the emerging markets, decline in oil prices, and health insurance reforms globally. However, low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes have been hampering market growth.

These are the latest findings of Reports and Data (New York City, NY, USA), a market research and consulting company.

Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth of the global clinical immunoanalyzers market. However, rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations could hamper market growth.

Other factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing diseases in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology.

Geographically, North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, the healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus on the developing regions, especially the emerging economies of Asia Pacific.

Related Links:
Reports and Data 

Gold Supplier
HAI Assay Quality Control
Amplichek II
Gold Supplier
Automated, Random Access Chemistry Analyzer
LIDA 300
Platinum Supplier
Respiratory Virus Multiplex Test
Respiratory Virus 12 Types Nucleic Acid Detection Kit
Silver Supplier
Urea Breath Test
13C-Urea Breath Test

Print article


Molecular Diagnostics

view channel
Image: New chip could make treating metastatic cancer easier and faster (Photo courtesy of Georgia Institute of Technology)

Simple Blood Test Detection Method Could Revolutionize Cancer Treatment

Cancer spreads via circulating tumor cells (CTCs) that travel through the blood to other organs, and they are nearly impossible to track. When a tumor starts metastasizing, it sheds its cell into the blood.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.